ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
38 hedge funds and large institutions have $4.58M invested in Oncternal Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
38
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$147K | |
| 2 | +$79.7K | |
| 3 | +$31.7K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$19.5K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$13.5K |
Top Sellers
| 1 | -$144K | |
| 2 | -$138K | |
| 3 | -$102K | |
| 4 |
Corient Private Wealth
Miami,
Florida
|
-$27.5K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
-$16.2K |